Therapeutic efficacy of canagliflozin against hepatocarcinogenesis induced by CDD/DEN/TAA in a rat model: regulation of AMPK/HIF-1α/YAP-1/TAZ signaling pathwaysHany M. Fayed, Rehab F. Abdel‐Rahman, Ola A. Sharaf et al.|Naunyn-Schmiedeberg s Archives of Pharmacology|2025Cited by 9
Therapeutic potential of canagliflozin in DEN/TAA-induced renal cancer: mechanistic insights into NLRP3/IL-6/STAT3 and AMPK signaling and oxidative stress regulationRehab F. Abdel‐Rahman, Marawan A. Elbaset, Mahdi H. Alsugoor et al.|Saudi Pharmaceutical Journal|2025Cited by 2